These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 24007843)
1. Update on allergen immunotherapy for treatment of allergic diseases. Kwong KY; Leibel S Adv Pediatr; 2013; 60(1):141-65. PubMed ID: 24007843 [No Abstract] [Full Text] [Related]
2. [Allergy: who should be hyposensitized? Indications and practice of specific hyposensitization treatment of allergic diseases]. Wüthrich B ZFA (Stuttgart); 1984 Jan; 60(2):67-75. PubMed ID: 6702271 [No Abstract] [Full Text] [Related]
3. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy]. Scheinmann P; Pham Thi N; Karila C; de Blic J Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361 [TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy. Cochard MM; Eigenmann PA J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352 [No Abstract] [Full Text] [Related]
5. Multiallergen immunotherapy for allergic rhinitis and asthma. Nelson HS J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653 [TBL] [Abstract][Full Text] [Related]
6. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis]. Pfaar O; Hörmann K; Klimek L MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935 [TBL] [Abstract][Full Text] [Related]
7. [Subcutaneous allergen-specific immunotherapy in patients with asthma and allergic rhinitis. 21st century]. Martín JP Rev Alerg Mex; 2009; 56(2):27-9. PubMed ID: 19526950 [No Abstract] [Full Text] [Related]
8. The health economics of allergen immunotherapy. Hankin CS; Cox L; Bronstone A Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823 [TBL] [Abstract][Full Text] [Related]
9. Clinical bystander effect exerted by allergen immunotherapy: a hypothesis. Ciprandi G Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):62-3. PubMed ID: 25781197 [TBL] [Abstract][Full Text] [Related]
10. Sublingual immunotherapy. Lin SY; Leatherman B Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059 [TBL] [Abstract][Full Text] [Related]
11. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of radioallergosorbent test-based allergen immunotherapy in treatment of perennial allergic rhinitis and asthma. Yeoh KH; Wang DY; Gordon BR Otolaryngol Head Neck Surg; 2004 Nov; 131(5):673-8. PubMed ID: 15523447 [TBL] [Abstract][Full Text] [Related]
13. Higher evidence for specific immunotherapy than reported in the ARIA update. Justicia JL; Mullol J J Allergy Clin Immunol; 2008 Feb; 121(2):536; author reply 536. PubMed ID: 18061656 [No Abstract] [Full Text] [Related]
14. Do indications to sublingual immunotherapy need to be revised? Incorvaia C; Mauro M J Allergy Clin Immunol; 2010 Jan; 125(1):277; author reply 277-8. PubMed ID: 20109757 [No Abstract] [Full Text] [Related]